1. Analysis of time-to-treatment discontinuation of targeted therapy, immunotherapy, and chemotherapy in clinical trials of patients with non-small-cell lung cancer. (22nd February 2019) Authors: Blumenthal, G M; Gong, Y; Kehl, K; Mishra-Kalyani, P; Goldberg, K B; Khozin, S; Kluetz, P G; Oxnard, G R; Pazdur, R Journal: Annals of oncology Issue: Volume 30:Number 5(2019) Page Start: 830 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy. (26th February 2018) Authors: McCoach, C E; Blumenthal, G M; Zhang, L; Myers, A; Tang, S; Sridhara, R; Keegan, P; Pazdur, R; Doebele, R C; Kazandjian, D Journal: Annals of oncology Issue: Volume 30:Number 3(2019) Page Start: 492 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗